Abstract 2361: An ex vivo organoid study to identify biomarkers of sensitivity to ST316, a clinical-stage β-catenin antagonist peptide
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Sapience Therapeutics
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409634382
